CDH1 and neoplasm: We also found there was significant correlation between the expression of E-cadherin and lymphatic metastasis, hepatic metastases and UICC stage, and the five-year survival rate in E-cadherin positive expression group was 61.4% and in negative expression group was 26.3%, this indicates that E-cadherin is an important marker of tumor aggressiveness.